SITADOSE-DM FORTE

MRP

MRP 399/-STRIP

Description

• Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate IP eq. to Dapagliflozin 10mg +Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg +Metformin Hydrochloride IP 1000mg (In extended relese form) Excipients. q.s.

Doses

• As directed by the Physician

Indication

• Dapagliflozin+Sitagliptin is used in the treatment of type 2 diabetes mellitus. Dapagliflozin + Sitagliptin is a combination of two antidiabetic medications. Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels.